Virtual 2020

Browse:
Pre-Congress Content
Sunday, 06.09.2020
Monday, 07.09.2020
Tuesday, 08.09.2020
Wednesday, 09.09.2020

 

View the presentations you missed during Congress!

More than 1,100 webcasts and slide presentations, 3,500 e-posters and 4,000 abstracts from the Virtual Congress 2020 and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2020; 55: Suppl. 65, abstract number.


Monoclonal antibodies in asthma

E-poster session
Chairs: P. Berger (Bordeaux, France), A. Licari (Pavia (PV), Italy)
Differences in the response to treatment with monoclonal antibodies according to age
A. Gomez-Larrauri (Barakaldo-Bizkaia, Spain), B. Ortiz De Urbina (Barakaldo-Bizkaia, Spain), J. Andia (Barakaldo-Bizkaia, Spain), E. Garay (Barakaldo-Bizkaia, Spain), A. Rezola (Barakaldo-Bizkaia, Spain), S. Pedrero (Barakaldo-Bizkaia, Spain), P. Sobradillo (Barakaldo-Bizkaia, Spain), E. Lopez De Santamaría (Barakaldo-Bizkaia, Spain), L. Martínez (Barakaldo-Bizkaia, Spain), M. Iriberri (Barakaldo-Bizkaia, Spain), N. Marina (Barakaldo-Bizkaia, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Clinical indicators of treatment response to Mepolizumab at 12 weeks
Y. Pang (Nottingham, United Kingdom), I. Stewart (Nottingham, United Kingdom), T. Harrison (Nottingham, United Kingdom), I. Sayers (Nottingham, United Kingdom), D. Shaw (Nottingham, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Mepolizumab in real-life treatment of severe eosinophilic asthma
E. Voláková (Olomouc 9, Czech Republic), J. Zatloukal (Olomouc 9, Czech Republic)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Real world outcomes of Mepolizumab for severe asthma in Wales a retrospective analysis.
A. Harries (Cardiff, United Kingdom), K. Pink (Cardiff, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Mepolizumab reduces nasal symptoms in asthmatic patients with chronic rhino-sinusitis and nasal polyposis: a 12 months real-life study
M. Maniscalco (Telese (BN), Italy), A. Detoraki (Napoli (NA), Italy), M. D’Amato (Napoli (NA), Italy), R. Giacco (Napoli (NA), Italy), C. Calabrese (Napoli (NA), Italy), . Boccia (Napoli (NA), Italy), E. Tremante (Napoli (NA), Italy), R. Poto (Napoli (NA), Italy), G. Quaremba (Napoli (NA), Italy), G. Spadaro (Napoli (NA), Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Evolution of patients with severe asthma treated with mepolizumab
A. Martinez Mesa (Malaga, Spain), E. Cabrera Cesar (Malaga, Spain), A. Aguilar Galvez (Malaga, Spain), N. Reina Marfil (Malaga, Spain), E. Sanchez Alvarez (Malaga, Spain), M. Fernandez Aguirre (Malaga, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effetiveness of biological treatment in severe asthma difficult to control (SADC)
M. Morón Ortiz (Huelva, Spain), J. Hilares Vera (Huelva, Spain), J. Lancha Dominguez (Huelva, Spain), C. Puchaes Manchón (Huelva, Spain), J. Sánchez-Ramos (Huelva, Spain), A. Pereira Vega (Huelva, Spain)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Omalizumab versus mepolizumab in severe asthma: a propensity score matched efficiency retrospective cohort study
C. Claudia (Catania, Italy), R. Campisi (Catania, Italy), S. Nolasco (Catania, Italy), E. Heffler (Milano, Italy), G. Valenti (Palermo, Italy), C. Pelaia (Catanzaro, Italy), A. Noto (Messina, Italy), G. Pelaia (Catanzaro, Italy), N. Crimi (Catania, Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan
H. Nagase (Tokyo, Japan), J. Tamaoki (Tokyo, Japan), T. Suzuki (Tokyo, Japan), Y. Nezu (Tokyo, Japan), A. Cole (Collegeville, United States of America), S. Yang (Collegeville, United States of America), G. Mu (Collegeville, United States of America), M. Katsumata (Tokyo, Japan), M. Komatsubara (Tokyo, Japan), R. Alfonso (Collegeville, United States of America)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Predictor of benralizumab for patients with severe eosinophilic asthma: a retrospective, real-life study
T. Numata (Tokyo, Japan), H. Miyagawa (Tokyo, Japan), K. Okuda (Tokyo, Japan), H. Utsumi (Tokyo, Japan), M. Hashimoto (Tokyo, Japan), S. Minagawa (Tokyo, Japan), T. Ishikawa (Tokyo, Japan), H. Hara (Tokyo, Japan), J. Araya (Tokyo, Japan), K. Kuwano (Tokyo, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
The characteristics of treatment failure with omalizumab in patients with severe asthma: The impact of eosinophilic complication
T. Akaba (Tokyo, Japan), M. Kondo (Tokyo, Japan), A. Kurokawa (Tokyo, Japan), K. Takeyama (Tokyo, Japan), E. Tagaya (Tokyo, Japan)
Congress or journal article abstract
Congress or journal article abstract
Benralizumab for severe asthma associated with extra-airway eosinophilic diseases
M. Toyoshima (Hamamatsu, Japan), K. Koda (Hamamatsu, Japan), T. Nozue (Hamamatsu, Japan), T. Suda (Hamamatsu, Japan)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
ABPA relapse after discontinuation of omalizumab
C. Bucca (Torino (TO), Italy), L. Brussino (Torino (TO), Italy), I. Ridolfi (Torino (TO), Italy), S. Nicola (Torino (TO), Italy), G. Rolla (Torino (TO), Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Differential treatment response to mepolizumab in severe eosinophilic asthma with nasal polyps
N. Tan (Singapore, Singapore), Y. Ong (Singapore, Singapore), M. Mukherjee (Hamilton, Canada), S. Chao (Singapore, Singapore), W. Tan (Singapore, Singapore), M. Liew (Singapore, Singapore), X. Xu (Singapore, Singapore), Y. Sng (Singapore, Singapore), D. Wang (Singapore, Singapore), W. Wong (Singapore, Singapore), P. Nair (Hamilton, Canada), V. Angeli (Singapore, Singapore), H. Lim (Singapore, Singapore)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis
S. Nolasco (Catania, Italy), C. Crimi (Catania, Italy), R. Campisi (Catania, Italy), G. Cacopardo (Catania, Italy), R. Intravaia (Catania, Italy), M. Porto (Catania, Italy), N. Crimi (Catania, Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Long term efficacy and safety of omalizumab in patients with allergic asthma-A real life study
A. Papaioannou (Chaidari, Athens(Athens), Greece), M. Mplizou (Chaidari,(Athens), Greece), K. Porpodis (Thessaloniki, Greece), E. Fouka (Thessaloniki, Greece), E. Zervas (Athens, Greece), K. Samitas (Athens, Greece), M. Markatos (Chania, Greece), S. Papiris (Chaidari, Athens(Athens), Greece), M. Gaga (Athens, Greece), D. Papakosta (Thessaloniki, Greece), S. Loukides (Chaidari, Athens(Athens), Greece)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy
O. Elneima (Leicester, United Kingdom), W. Ibrahim (Leicester, United Kingdom), C. Boddy (Leicester, United Kingdom), A. Murphy (Leicester, United Kingdom), P. Bradding (Leicester, United Kingdom), C. Brightling (Leicester, United Kingdom), S. Siddiqui (Leicester, United Kingdom)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Super-response to dupilumab therapy in a patient with severe asthma and ABPA – a case report
C. Mümmler (München, Germany), B. Kemmerich (München, Germany), K. Milger-Kneidinger (München, Germany)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster
Mepolizumab is effective in severe eosinophilic asthmatics: an Austrian real-life study.
A. Renner (Wien, Austria), K. Marth (Wien, Austria), K. Patocka (Wien, Austria), W. Pohl (Wien, Austria)
Congress or journal article abstract
Congress or journal article abstract
Serum YKL-40 modulation in severe asthma patients treated with Mepolizumab
D. Bagnasco (GENOVA (GE), Italy), A. Riccio (GENOVA (GE), Italy), L. De Ferrari (GENOVA (GE), Italy), M. Caminati (Verona, Italy), A. Massolo (Pisa, Italy), G. Senna (Verona, Italy), G. Passalacqua (GENOVA (GE), Italy)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster